Insmed
INSM
438 hedge funds and large institutions have $13.3B invested in Insmed in 2024 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 178 increasing their positions, 144 reducing their positions, and 44 closing their positions.
70% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 44
24% more repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 144
20% more call options, than puts
Call options by funds: $235M | Put options by funds: $197M
7% more funds holding in top 10
Funds holding in top 10: 27 → 29 (+2)
6% more funds holding
Funds holding: 413 → 438 (+25)
3% less capital invested
Capital invested by funds: $13.7B → $13.3B (-$438M)
1.8% less ownership
Funds ownership: 109.43% → 107.64% (-1.8%)
Top Buyers
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$177M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$77.5M |
| 3 |
BlackRock
New York
|
+$76.5M |
| 4 |
Holocene Advisors
New York
|
+$49.5M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$49.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$168M |
| 2 |
EP
Eversept Partners
New York
|
-$79.5M |
| 3 |
VPC
Vestal Point Capital
New York
|
-$50.4M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$50.4M |
| 5 |
Man Group
London,
United Kingdom
|
-$42.3M |
INSM Hedge Fund Activity: Q4 2024 in Review
438 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2024, worth a combined $13.3B — down 3.2% from $13.7B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new INSM positions and 44 closed out — a net gain of 31 holders — while 178 added to existing stakes and 144 trimmed.
The largest buyer was Darwin Global Management, adding an estimated $177M. The largest seller was Fidelity Investments, cutting an estimated $168M.
- 438 institutional investors held Insmed (INSM) as of Q4 2024, up from 413 in Q3 2024.
- Funds reported $13.3B of Insmed stock for Q4 2024, down 3.2% quarter-over-quarter.
- 75 funds opened new Insmed positions in Q4 2024 and 44 closed out, a net change of +31 holders.
- The largest Insmed buyer in Q4 2024 was Darwin Global Management, an estimated $177M added.
- The largest Insmed seller in Q4 2024 was Fidelity Investments, an estimated $168M sold.
Based on aggregated 13F filings for Q4 2024.